Coeptis Pharmaceuticals - Seven Development Stage Drug Products - Ownership and Business Overview

Life ScienceCompany

Coeptis Pharmaceuticals - Seven Development Stage Drug Products Ownership

Who owns Coeptis Pharmaceuticals - Seven Development Stage Drug Products?

Coeptis Pharmaceuticals - Seven Development Stage Drug Products is owned by ANI Pharmaceuticals. It was acquired on June 18, 2019.

Coeptis Pharmaceuticals - Seven Development Stage Drug Products Business Overview

Where is Coeptis Pharmaceuticals - Seven Development Stage Drug Products headquartered?

Coeptis Pharmaceuticals - Seven Development Stage Drug Products is headquartered in Wexford, Pennsylvania.

What sector is Coeptis Pharmaceuticals - Seven Development Stage Drug Products in?

Coeptis Pharmaceuticals - Seven Development Stage Drug Products is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 245 acquisitions of life science companies in 2019, including 40 acquisitions by private equity firms, and 205 by strategics.

Coeptis Pharmaceuticals, Inc. - Seven Development Stage Drug Products

Wexford, Pennsylvania 15090
United States,
(724) 934-6467

Coeptis Pharmaceuticals, Inc. - Seven Development Stage Drug Products includes three oral and four injectable products and has a combined current annual U.S. market value of $1.02 billion according to IQVIA and ANI estimates. Six of the products are currently in development at third parties with commercial manufacturing sites already established. The seventh product, a liposomal-based injectable, is in development at a third party and ANI will seek to identify a commercial manufacturing partner in the near-term.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.